A class of novel Schiff’s bases: Synthesis, therapeutic action for chronic pain, anti-inflammation and 3D QSAR analysis Original Research Article

To discover analgesics for treating chronic pain 17 novel Schiff’s bases, N,N′-(Z-allylidene-1,3-diyl)bisamino acid methyl esters were prepared from 1,1,3,3,-tetramethoxypropane and amino acid methyl esters. On tail-flick mouse model 20 μmol/kg of these Schiff’s bases were orally administered, the analgesic action started 30 min after administration, reached the maximum 120 min after administration, and at 180 min this action was still observed. On a xylene-induced ear edema mouse model 20 μmol/kg of these Schiff’s bases exhibited desirable anti-inflammation. Thus the present Schiff’s bases are able to treat chronic pain from inflammation. The effect of the side chains of the amino acid residues of these Schiff’s bases on the analgesic activity was explained with 3D QSAR.